Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications

Up a Hydrophobic Creek with a Short Paddle

(2010) Raymond E. Hulse et al.   CELL

A Shaker K+ Channel with a Miniature Engineered Voltage Sensor

(2010) Yanping Xu et al.   CELL

Kv1.5-Kvβ Interactions: Molecular Determinants and Pharmacological Consequences

(2010) Teresa Gonzalez et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Molecular Basis for a High-Potency Open-Channel Block of Kv1.5 Channel by the Endocannabinoid Anandamide

(2010) E. G. Moreno-Galindo et al.   MOLECULAR PHARMACOLOGY

Common variants in KCNN3 are associated with lone atrial fibrillation

(2010) Patrick T Ellinor et al.   NATURE GENETICS

Antiarrhythmic therapy in atrial fibrillation

(2010) Ursula Ravens   PHARMACOLOGY & THERAPEUTICS

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner

(2009) Adriana Barana et al.   CARDIOVASCULAR RESEARCH

Antiarrhythmic Drug-Induced Internalization of the Atrial-Specific K + Channel Kv1.5

(2009) Sarah M. Schumacher et al.   CIRCULATION RESEARCH

Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery

(2009) Peter R. Kowey et al.   Circulation-Arrhythmia and Electrophysiology

Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation

(2009) S. Kaab et al.   EUROPEAN HEART JOURNAL

Atrial-selective sodium channel block for the treatment of atrial fibrillation

(2009) Alexander Burashnikov et al.   EXPERT OPINION ON EMERGING DRUGS

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

(2009) Juan Tamargo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation

(2009) Yiqing Yang et al.   JOURNAL OF HUMAN GENETICS

The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes

(2008) Joëlle Abi-Char et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation

(2008) T Christ et al.   BRITISH JOURNAL OF PHARMACOLOGY

Genetics of Atrial Fibrillation

(2008) Steven A. Lubitz et al.   CARDIOLOGY CLINICS

Four and a half LIM protein 1: a partner for KCNA5 in human atrium

(2008) Z. Yang et al.   CARDIOVASCULAR RESEARCH

Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis

(2008) D. Dobrev et al.   CARDIOVASCULAR RESEARCH

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

(2008) Denis Roy et al.   CIRCULATION

Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?

(2008) Joachim R Ehrlich et al.   CURRENT OPINION IN CARDIOLOGY

Structural determinants of Kvβ1.3-induced channel inactivation: a hairpin modulated by PIP2

(2008) Niels Decher et al.   EMBO JOURNAL

Role of potassium currents in cardiac arrhythmias

(2008) U. Ravens et al.   EUROPACE

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

(2008) John W Ford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Modeling the binding modes of Kv1.5 potassium channel and blockers

(2008) Qian Yang et al.   JOURNAL OF MOLECULAR GRAPHICS & MODELLING

Ligand Binding to the Voltage-Gated Kv1.5 Potassium Channel in the Open State—Docking and Computer Simulations of a Homology Model

(2007) Martin Andér et al.   BIOPHYSICAL JOURNAL